Oxidative stress during leukocyte absorption apheresis

Journal of Clinical Apheresis

Volumn 18, Issue 2, 2003, Pages 61-66

  Hirayama, Aki ^a   Nagase, Sohji ^a   Ueda, Atsushi ^b   Ishizu, Takashi ^c   Taru, Yoshinori ^c   Yoh, Keigyou ^a   Hirayama, Kouichi ^a   Kobayashi, Masaki ^d   Koyama, Akio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Namegata General Hospital   (Japan)

^c Tsukuba Central Hospital   (Japan)

^d Tokyo Medical University Ibaraki Medical Center   (Japan)

Author keywords

Biocompatibility; Electron spin resonance; Hydroxyl radical; Radical scavenging activity; Thiobarbit uric acid reactive substances

Indexed keywords

CELLULOSE ACETATE; HYDROXYL RADICAL; POLYETHYLENE TEREPHTHALATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ELECTRON SPIN RESONANCE; EVALUATION; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HUMAN; LEUKAPHERESIS; LEUKOCYTE ABSORPTION APHERESIS; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; MEASUREMENT; OXIDATIVE STRESS; RISK ASSESSMENT; SCAVENGING SYSTEM; SIGNAL PROCESSING; TECHNIQUE; ULCERATIVE COLITIS;

BIOCOMPATIBLE MATERIALS; CELLULOSE; CHROMATOGRAPHY; COLITIS, ULCERATIVE; HUMANS; HYDROXYL RADICAL; LEUKAPHERESIS; OXIDATIVE STRESS; POLYETHYLENE TEREPHTHALATES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0042667033     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10054     Document Type: Article

References (21)

1. Hidaka T, Suzuki K, Kawakami M, Okada M, Kataharada K, Shinohara T, Takamizawa-Matsumoto M, Ohsuzu F. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apheresis 2001;16:74-81.
2. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001;16:1-9.
3. Yamaji K, Tsuda H, Hashimoto H. Current topics on cytapheresis technologies. Ther Apher 2001;5:287-292.
4. Ohara M, Saniabadi Ar, Kokuma S, Hirata I, Adachi M, Agishi T, Kasukawa R. Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 1997;21:989-994.
5. Kashiwagi N, Hirata I, Kasukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998;2:134-141.
6. Hakim RM. Influence of the dialysis membrane on outcome of ESRD patients. Am J Kidney Dis 1998;32:S71-75.
7. Rosenkranz AR, Templ E, Traindl O, Heinzl H, Zlabinger GJ. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin Exp Immunol 1994;98:300-305.
8. Nagase S, Aoyagi K, Hirayama A, Gotoh M, Ueda A, Tomida C, Kamezaki T, Nagai Y, Kikuchi H, Koyama A. Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance. J Am Soc Nephrol 1997;8:1157-1163.
9. Hirayama A, Nagase S, Gotoh M, Ueda A, Ishizu T, Yoh K, Aoyagi K, Terao J, Koyama A. Reduced serum hydroxyl radical scavenging activity in erythropoietin therapy resistant renal anemia. Free Radic Res 2002;36:1155-1161.
10. Hirayama A, Nagase S, Gotoh M, Takemura K, Tomida C, Ueda A, Aoyagi K, Terao J, Koyama A. Hemodialysis does not influence the peroxidative state already present in uremia. Nephron 2000;86:436-440.
11. Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T. Leukocytapheresis therapy for severe ulcerative colitis. Ther Apher 1998;2:101-104.
12. Gotoh M, Nagase S, Aoyagi K, Hirayama A, Takemura K, Ueda A, Tomida C, Kikuchi H, Koyama A. Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease. Nephrol Dial Transplant 1997;12:713-717.
13. Yoh K, Ino M, Nakazato M, Hiratsuka T, Ishizu T, Hirayama A, Mikami T, Tachibana S, Koyama A. Effect of different dialyzers on defensins during hemodialysis. Clin Exp Nephrol 2001;5:163-167.
14. Shimazu T, Ominato M, Toyama K, Yasuda T, Sato T, Maeba T, Owada S, Ishida M. Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int Suppl 2001;78:S137-143.
15. Mori A, Liu J, Wang X, Kawai M. Free radical scavenging by brain homogenate: implication to free radical damage and antioxidant defense in brain. Neurochem Int 1994;24:201-207.
16. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 1988;33:6S-15S.
17. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, Grisham MB, Ross Cr, Granger DN. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001;194:1207-1218.
18. Simmonds NJ, Allen RE, Stevens TR, Van Someren RN, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992;103:186-196.
19. Woods HF, Nandakumar M. Improved outcome for haemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 2000;15(Suppl 1):36-42.
20. Locatelli F, Manzoni C, Di Filippo S. The importance of convective transport. Kidney Int 2002;61(Suppl 80):115-120.
21. Keshavarzian A, Haydek JM, Jacyno M, Holmes EW, Harford F. Modulatory effects of the colonic milieu on neutrophil oxidative burst: a possible pathogenic mechanism of ulcerative colitis. J Lab Clin Med 1997;130:216-225.